467 related articles for article (PubMed ID: 15159324)
1. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps.
Ulrich CM; Bigler J; Sparks R; Whitton J; Sibert JG; Goode EL; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):889-93. PubMed ID: 15159324
[TBL] [Abstract][Full Text] [Related]
2. Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.
Poole EM; Bigler J; Whitton J; Sibert JG; Potter JD; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):502-8. PubMed ID: 16537708
[TBL] [Abstract][Full Text] [Related]
3. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
4. TGFbeta1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps.
Sparks R; Bigler J; Sibert JG; Potter JD; Yasui Y; Ulrich CM
Int J Epidemiol; 2004 Oct; 33(5):955-61. PubMed ID: 15020570
[TBL] [Abstract][Full Text] [Related]
5. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
[TBL] [Abstract][Full Text] [Related]
6. Inflammation-related gene polymorphisms and colorectal adenoma.
Gunter MJ; Canzian F; Landi S; Chanock SJ; Sinha R; Rothman N
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1126-31. PubMed ID: 16775170
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps.
Ulrich CM; Kampman E; Bigler J; Schwartz SM; Chen C; Bostick R; Fosdick L; Beresford SA; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):427-33. PubMed ID: 10794488
[TBL] [Abstract][Full Text] [Related]
8. DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps.
Jung AY; Poole EM; Bigler J; Whitton J; Potter JD; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):330-8. PubMed ID: 18268116
[TBL] [Abstract][Full Text] [Related]
9. Genetic variability in prostaglandin synthesis, fish intake and risk of colorectal polyps.
Poole EM; Bigler J; Whitton J; Sibert JG; Kulmacz RJ; Potter JD; Ulrich CM
Carcinogenesis; 2007 Jun; 28(6):1259-63. PubMed ID: 17277229
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of colorectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps.
Huang EH; Whelan RL; Gleason NR; Maeda JS; Terry MB; Lee SW; Neugut AI; Forde KA
Surg Endosc; 2001 Jul; 15(7):646-8. PubMed ID: 11591960
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals.
MartÃnez ME; McPherson RS; Levin B; Annegers JF
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):703-7. PubMed ID: 8672985
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential?
Morimoto LM; Newcomb PA; Ulrich CM; Bostick RM; Lais CJ; Potter JD
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1012-8. PubMed ID: 12376501
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for advanced colorectal adenomas: a pooled analysis.
Terry MB; Neugut AI; Bostick RM; Sandler RS; Haile RW; Jacobson JS; Fenoglio-Preiser CM; Potter JD
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):622-9. PubMed ID: 12101109
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs.
St Germaine CG; Bogaty P; Boyer L; Hanley J; Engert JC; Brophy JM
Am J Cardiol; 2010 Jun; 105(12):1740-5. PubMed ID: 20538124
[TBL] [Abstract][Full Text] [Related]
15. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
Bigler J; Whitton J; Lampe JW; Fosdick L; Bostick RM; Potter JD
Cancer Res; 2001 May; 61(9):3566-9. PubMed ID: 11325819
[TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas.
Ulrich CM; Bigler J; Bostick R; Fosdick L; Potter JD
Cancer Res; 2002 Jun; 62(12):3361-4. PubMed ID: 12067974
[TBL] [Abstract][Full Text] [Related]
17. Smoking exposure as a risk factor for prevalent and recurrent colorectal adenomas.
Reid ME; Marshall JR; Roe D; Lebowitz M; Alberts D; Battacharyya AK; Martinez ME
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1006-11. PubMed ID: 14578135
[TBL] [Abstract][Full Text] [Related]
18. Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women?
Wolf LA; Terry PD; Potter JD; Bostick RM
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):676-83. PubMed ID: 17416757
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
[TBL] [Abstract][Full Text] [Related]
20. Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake.
Ulrich CM; Bigler J; Whitton JA; Bostick R; Fosdick L; Potter JD
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):875-82. PubMed ID: 11489754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
